Life sciences innovation in emerging markets
Learn about emerging markets innovation opportunities and challenges and how innovation can be promoted and protected in emerging markets.

Managing pathways to convergence in the life sciences industry
This paper highlights examples of convergence in the life sciences industry, identifies the driving forces behind the trend and discusses the pathways to convergence in today's marketplace.

Innovation in the life sciences industry
Bob Go, Global Managing Director of Deloitte’s Life Sciences and Health Care Industry Group presented two papers at the 2007 World Economic Forum. These papers examine innovation in the sector, including key trends and the opinions of top life sciences executives.

Services for life: Competing on service excellence in the medical device industry
Aging demographics and emerging markets are creating a growing demand for more and better health care solutions while technological advances are creating new innovation opportunities in the medical device industry. At the same time, a series of industry changes is forcing medical device manufacturers to rethink their business models.

Medicaid makeover: Six tough (and unavoidable) choices on the road to reform
This study urges U.S. states to address six tough choices that go to the heart of what kind of a program they want to provide and presents a new approach to Medicaid reform.

Laboratories of innovation: Leveraging emerging markets for commercial success
Emerging markets are becoming the catalysts for new product and service innovation. Long-term success, however, will take more than simply making minor adjustments to existing products, lowering prices and developing new sales channels.

Critical factors in alliance formation
This study examines the growing trend of big pharma and biopharma companies forming alliances with small biotech enterprises.

Growth strategies for large biopharma companies
Large biopharma companies are facing unprecedented challenges to further growth as a result of technological developments, more intense competition and unresolved political and regulatory issues. This report outlines three strategies to help meet these challenges.